Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric antifungal therapy

S F Friedlander1, S Suarez

  • 1Department of Medicine, University of California, San Diego School of Medicine, USA.

Dermatologic Clinics
|August 15, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventive strategies in paediatric cardiovascular surgery: impact on surgical site infections and beyond.

The Journal of hospital infection·2024
Same author

Occurrence and fate of CECs (OMPs, ARGs and pathogens) during decentralised treatment of black water and grey water.

The Science of the total environment·2024
Same author

Discovery of endogenous nitroxyl as a new redox player in Arabidopsis thaliana.

Nature plants·2022
Same author

An study on the influence of collagen fiber directions in TAVs performance using FEM.

Journal of the mechanical behavior of biomedical materials·2021
Same author

Minimization of dissolved methane, nitrogen and organic micropollutants emissions of effluents from a methanogenic reactor by using a preanoxic MBR post-treatment system.

The Science of the total environment·2019
Same author

Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.

Lupus·2018

New antifungal therapies offer hope for children with difficult-to-treat fungal infections like tinea capitis. While not yet FDA-approved for pediatric use, these agents may provide alternatives for refractory cases, requiring careful consideration of risks and benefits.

Area of Science:

  • Dermatology
  • Pediatric Infectious Diseases
  • Mycology

Background:

  • Superficial dermatophyte infections, including tinea capitis, are common in children.
  • Griseofulvin is the traditional treatment but faces increasing resistance.
  • Refractory and slow-response cases necessitate alternative therapeutic strategies.

Purpose of the Study:

  • To review emerging antifungal therapies for pediatric dermatophyte infections.
  • To discuss the potential role of new agents in treating resistant fungal infections.
  • To highlight the importance of understanding risks and benefits of off-label drug use.

Main Methods:

  • Literature review of current and emerging antifungal treatments.
  • Analysis of clinical data on new antifungal agents for pediatric use.

Related Experiment Videos

  • Discussion of treatment guidelines and off-label considerations.

    • Main Results:

    • Several new antifungal agents show promise for treating pediatric dermatophyte infections.
    • Some new agents may be effective against griseofulvin-resistant strains.
    • Off-label use requires careful patient selection and monitoring.

    Conclusions:

    • New antifungal therapies represent a potential advancement in managing pediatric dermatophyte infections.
    • Careful consideration of efficacy, safety, and regulatory status is crucial for off-label use.
    • Further research and FDA approval are needed to establish definitive roles for these agents.